NCT00115245View on ClinicalTrials.gov

Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

November 30, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

Chronic Hepatitis B

Interventions

DRUG

Telbivudine (LdT)

DRUG

Adefovir Dipivoxil

Trial Locations (15)

Unknown

Los Angeles

Pasadena

San Francisco

Miami

Clayton

Wooloongabba

Calgary

Toronto

Winnipeg

Hong Kong

Paris

Singapore

Seoul

Taipei

Bangkok

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Novartis

INDUSTRY